- Home
- / Veralox Therapeutics
Veralox Therapeutics
Total Funding
$5.4 M
Veralox Therapeutics Summary
Company Summary
- Overview
- Veralox Therapeutics is a preclinical stage company. It develops small molecule therapeutics for unmet medical needs, targeting 12-lipoxygenase.
- Type
- Private
- Status
- Active
- Founded
- 2018
- HQ
- Frederick, MD, US | view all locations
- Website
- https://veralox.com
- Cybersecurity rating
Table of Contents
Key People
Matthew B. Boxer, Co-Founder and Chief Operating Officer
Katie Ellias, Director
Alex Martin, Chairman
LocationsView all
1 location detected
Frederick, MD HQ
United States
4539 Metropolitan Ct